CN109354615B - LEPTO1 and application of encoding protein thereof in rice fertility control - Google Patents
LEPTO1 and application of encoding protein thereof in rice fertility control Download PDFInfo
- Publication number
- CN109354615B CN109354615B CN201811452764.9A CN201811452764A CN109354615B CN 109354615 B CN109354615 B CN 109354615B CN 201811452764 A CN201811452764 A CN 201811452764A CN 109354615 B CN109354615 B CN 109354615B
- Authority
- CN
- China
- Prior art keywords
- lepto1
- protein
- sequence
- gene
- rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 106
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 62
- 235000007164 Oryza sativa Nutrition 0.000 title abstract description 52
- 235000009566 rice Nutrition 0.000 title abstract description 49
- 230000035558 fertility Effects 0.000 title abstract description 21
- 240000007594 Oryza sativa Species 0.000 title description 4
- 239000000126 substance Substances 0.000 claims abstract description 9
- 238000009395 breeding Methods 0.000 claims abstract description 8
- 230000001488 breeding effect Effects 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 7
- 108020004414 DNA Proteins 0.000 claims description 24
- 102000053602 DNA Human genes 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 108091033409 CRISPR Proteins 0.000 claims description 6
- 108091026890 Coding region Proteins 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 abstract description 52
- 241000209094 Oryza Species 0.000 abstract description 50
- 210000000349 chromosome Anatomy 0.000 abstract description 12
- 210000000130 stem cell Anatomy 0.000 abstract description 8
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 abstract description 7
- 238000002741 site-directed mutagenesis Methods 0.000 abstract description 6
- 238000010362 genome editing Methods 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 206010000210 abortion Diseases 0.000 abstract description 3
- 231100000176 abortion Toxicity 0.000 abstract description 3
- 238000003209 gene knockout Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 102000016267 Leptin Human genes 0.000 description 25
- 108010092277 Leptin Proteins 0.000 description 25
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 25
- 229940039781 leptin Drugs 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 19
- 239000013598 vector Substances 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000010367 cloning Methods 0.000 description 6
- 230000021121 meiosis Effects 0.000 description 5
- 238000000116 DAPI staining Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 3
- 206010021929 Infertility male Diseases 0.000 description 3
- 208000007466 Male Infertility Diseases 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 240000002582 Oryza sativa Indica Group Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 2
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 2
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 108010079547 glutamylmethionine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009405 line breeding Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000010152 pollination Effects 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 238000012070 whole genome sequencing analysis Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 1
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 1
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- XSLGWYYNOSUMRM-ZKWXMUAHSA-N Ala-Val-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XSLGWYYNOSUMRM-ZKWXMUAHSA-N 0.000 description 1
- BVLPIIBTWIYOML-ZKWXMUAHSA-N Ala-Val-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BVLPIIBTWIYOML-ZKWXMUAHSA-N 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- DXQIQUIQYAGRCC-CIUDSAMLSA-N Arg-Asp-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)CN=C(N)N DXQIQUIQYAGRCC-CIUDSAMLSA-N 0.000 description 1
- YHQGEARSFILVHL-HJGDQZAQSA-N Arg-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)O YHQGEARSFILVHL-HJGDQZAQSA-N 0.000 description 1
- PNIGSVZJNVUVJA-BQBZGAKWSA-N Arg-Gly-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O PNIGSVZJNVUVJA-BQBZGAKWSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- PYZPXCZNQSEHDT-GUBZILKMSA-N Arg-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N PYZPXCZNQSEHDT-GUBZILKMSA-N 0.000 description 1
- XRNXPIGJPQHCPC-RCWTZXSCSA-N Arg-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)O)C(O)=O XRNXPIGJPQHCPC-RCWTZXSCSA-N 0.000 description 1
- XEOXPCNONWHHSW-AVGNSLFASA-N Arg-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N XEOXPCNONWHHSW-AVGNSLFASA-N 0.000 description 1
- POOCJCRBHHMAOS-FXQIFTODSA-N Asn-Arg-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O POOCJCRBHHMAOS-FXQIFTODSA-N 0.000 description 1
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 1
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 1
- VWJFQGXPYOPXJH-ZLUOBGJFSA-N Asn-Cys-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)C(=O)N VWJFQGXPYOPXJH-ZLUOBGJFSA-N 0.000 description 1
- HJRBIWRXULGMOA-ACZMJKKPSA-N Asn-Gln-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJRBIWRXULGMOA-ACZMJKKPSA-N 0.000 description 1
- PQAIOUVVZCOLJK-FXQIFTODSA-N Asn-Gln-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PQAIOUVVZCOLJK-FXQIFTODSA-N 0.000 description 1
- UPALZCBCKAMGIY-PEFMBERDSA-N Asn-Gln-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UPALZCBCKAMGIY-PEFMBERDSA-N 0.000 description 1
- WPOLSNAQGVHROR-GUBZILKMSA-N Asn-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N WPOLSNAQGVHROR-GUBZILKMSA-N 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- PHJPKNUWWHRAOC-PEFMBERDSA-N Asn-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PHJPKNUWWHRAOC-PEFMBERDSA-N 0.000 description 1
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 1
- ALHMNHZJBYBYHS-DCAQKATOSA-N Asn-Lys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ALHMNHZJBYBYHS-DCAQKATOSA-N 0.000 description 1
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 1
- KSGAFDTYQPKUAP-GMOBBJLQSA-N Asn-Met-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KSGAFDTYQPKUAP-GMOBBJLQSA-N 0.000 description 1
- KEUNWIXNKVWCFL-FXQIFTODSA-N Asn-Met-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O KEUNWIXNKVWCFL-FXQIFTODSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- OOXUBGLNDRGOKT-FXQIFTODSA-N Asn-Ser-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OOXUBGLNDRGOKT-FXQIFTODSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 1
- YSYTWUMRHSFODC-QWRGUYRKSA-N Asn-Tyr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O YSYTWUMRHSFODC-QWRGUYRKSA-N 0.000 description 1
- GHWWTICYPDKPTE-NGZCFLSTSA-N Asn-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N GHWWTICYPDKPTE-NGZCFLSTSA-N 0.000 description 1
- AXXCUABIFZPKPM-BQBZGAKWSA-N Asp-Arg-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O AXXCUABIFZPKPM-BQBZGAKWSA-N 0.000 description 1
- UGIBTKGQVWFTGX-BIIVOSGPSA-N Asp-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O UGIBTKGQVWFTGX-BIIVOSGPSA-N 0.000 description 1
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 1
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 1
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 1
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 1
- HXVILZUZXFLVEN-DCAQKATOSA-N Asp-Met-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O HXVILZUZXFLVEN-DCAQKATOSA-N 0.000 description 1
- XUVTWGPERWIERB-IHRRRGAJSA-N Asp-Pro-Phe Chemical compound N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O XUVTWGPERWIERB-IHRRRGAJSA-N 0.000 description 1
- XQFLFQWOBXPMHW-NHCYSSNCSA-N Asp-Val-His Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O XQFLFQWOBXPMHW-NHCYSSNCSA-N 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- XRTISHJEPHMBJG-SRVKXCTJSA-N Cys-Asp-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XRTISHJEPHMBJG-SRVKXCTJSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WUAYFMZULZDSLB-ACZMJKKPSA-N Gln-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O WUAYFMZULZDSLB-ACZMJKKPSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- JSYULGSPLTZDHM-NRPADANISA-N Gln-Ala-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O JSYULGSPLTZDHM-NRPADANISA-N 0.000 description 1
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 1
- XWIBVSAEUCAAKF-GVXVVHGQSA-N Gln-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)N)N XWIBVSAEUCAAKF-GVXVVHGQSA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- SWDSRANUCKNBLA-AVGNSLFASA-N Gln-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SWDSRANUCKNBLA-AVGNSLFASA-N 0.000 description 1
- OREPWMPAUWIIAM-ZPFDUUQYSA-N Gln-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N OREPWMPAUWIIAM-ZPFDUUQYSA-N 0.000 description 1
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 1
- NYCVMJGIJYQWDO-CIUDSAMLSA-N Gln-Ser-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NYCVMJGIJYQWDO-CIUDSAMLSA-N 0.000 description 1
- BJVBMSTUUWGZKX-JYJNAYRXSA-N Gln-Tyr-His Chemical compound N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BJVBMSTUUWGZKX-JYJNAYRXSA-N 0.000 description 1
- ZZLDMBMFKZFQMU-NRPADANISA-N Gln-Val-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O ZZLDMBMFKZFQMU-NRPADANISA-N 0.000 description 1
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 1
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 1
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 1
- SYAYROHMAIHWFB-KBIXCLLPSA-N Glu-Ser-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYAYROHMAIHWFB-KBIXCLLPSA-N 0.000 description 1
- VNCNWQPIQYAMAK-ACZMJKKPSA-N Glu-Ser-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O VNCNWQPIQYAMAK-ACZMJKKPSA-N 0.000 description 1
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 1
- NZAFOTBEULLEQB-WDSKDSINSA-N Gly-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN NZAFOTBEULLEQB-WDSKDSINSA-N 0.000 description 1
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 1
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 1
- JPWIMMUNWUKOAD-STQMWFEESA-N Gly-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN JPWIMMUNWUKOAD-STQMWFEESA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- QSVMIMFAAZPCAQ-PMVVWTBXSA-N Gly-His-Thr Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QSVMIMFAAZPCAQ-PMVVWTBXSA-N 0.000 description 1
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 1
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 1
- BBTCXWTXOXUNFX-IUCAKERBSA-N Gly-Met-Arg Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O BBTCXWTXOXUNFX-IUCAKERBSA-N 0.000 description 1
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- QIVPRLJQQVXCIY-HGNGGELXSA-N His-Ala-Gln Chemical compound C[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(O)=O QIVPRLJQQVXCIY-HGNGGELXSA-N 0.000 description 1
- OMNVOTCFQQLEQU-CIUDSAMLSA-N His-Asn-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMNVOTCFQQLEQU-CIUDSAMLSA-N 0.000 description 1
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
- NTXIJPDAHXSHNL-ONGXEEELSA-N His-Gly-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NTXIJPDAHXSHNL-ONGXEEELSA-N 0.000 description 1
- LVXFNTIIGOQBMD-SRVKXCTJSA-N His-Leu-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O LVXFNTIIGOQBMD-SRVKXCTJSA-N 0.000 description 1
- 101000686942 Homo sapiens Histone-lysine N-methyltransferase PRDM16 Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 1
- NCSIQAFSIPHVAN-IUKAMOBKSA-N Ile-Asn-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N NCSIQAFSIPHVAN-IUKAMOBKSA-N 0.000 description 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 1
- AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
- JZBVBOKASHNXAD-NAKRPEOUSA-N Ile-Val-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N JZBVBOKASHNXAD-NAKRPEOUSA-N 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- CNNQBZRGQATKNY-DCAQKATOSA-N Leu-Arg-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N CNNQBZRGQATKNY-DCAQKATOSA-N 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 1
- OYQUOLRTJHWVSQ-SRVKXCTJSA-N Leu-His-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O OYQUOLRTJHWVSQ-SRVKXCTJSA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- RTIRBWJPYJYTLO-MELADBBJSA-N Leu-Lys-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N RTIRBWJPYJYTLO-MELADBBJSA-N 0.000 description 1
- JCFYLFOCALSNLQ-GUBZILKMSA-N Lys-Ala-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JCFYLFOCALSNLQ-GUBZILKMSA-N 0.000 description 1
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 1
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 1
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 1
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 1
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 1
- NKDSBBBPGIVWEI-RCWTZXSCSA-N Met-Arg-Thr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NKDSBBBPGIVWEI-RCWTZXSCSA-N 0.000 description 1
- ACYHZNZHIZWLQF-BQBZGAKWSA-N Met-Asn-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ACYHZNZHIZWLQF-BQBZGAKWSA-N 0.000 description 1
- CAODKDAPYGUMLK-FXQIFTODSA-N Met-Asn-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CAODKDAPYGUMLK-FXQIFTODSA-N 0.000 description 1
- OHMKUHXCDSCOMT-QXEWZRGKSA-N Met-Asn-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHMKUHXCDSCOMT-QXEWZRGKSA-N 0.000 description 1
- FJVJLMZUIGMFFU-BQBZGAKWSA-N Met-Asp-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FJVJLMZUIGMFFU-BQBZGAKWSA-N 0.000 description 1
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 1
- UOENBSHXYCHSAU-YUMQZZPRSA-N Met-Gln-Gly Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UOENBSHXYCHSAU-YUMQZZPRSA-N 0.000 description 1
- DBXMFHGGHMXYHY-DCAQKATOSA-N Met-Leu-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O DBXMFHGGHMXYHY-DCAQKATOSA-N 0.000 description 1
- LNXGEYIEEUZGGH-JYJNAYRXSA-N Met-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CC=CC=C1 LNXGEYIEEUZGGH-JYJNAYRXSA-N 0.000 description 1
- WYDFQSJOARJAMM-GUBZILKMSA-N Met-Pro-Asp Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WYDFQSJOARJAMM-GUBZILKMSA-N 0.000 description 1
- DBMLDOWSVHMQQN-XGEHTFHBSA-N Met-Ser-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DBMLDOWSVHMQQN-XGEHTFHBSA-N 0.000 description 1
- ZBLSZPYQQRIHQU-RCWTZXSCSA-N Met-Thr-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ZBLSZPYQQRIHQU-RCWTZXSCSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 1
- 101100350457 Oryza sativa subsp. japonica RR24 gene Proteins 0.000 description 1
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 1
- DOXQMJCSSYZSNM-BZSNNMDCSA-N Phe-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O DOXQMJCSSYZSNM-BZSNNMDCSA-N 0.000 description 1
- ZLAKUZDMKVKFAI-JYJNAYRXSA-N Phe-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O ZLAKUZDMKVKFAI-JYJNAYRXSA-N 0.000 description 1
- XWYXZPHPYKRYPA-GMOBBJLQSA-N Pro-Asn-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XWYXZPHPYKRYPA-GMOBBJLQSA-N 0.000 description 1
- JARJPEMLQAWNBR-GUBZILKMSA-N Pro-Asp-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JARJPEMLQAWNBR-GUBZILKMSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 1
- VWHJZETTZDAGOM-XUXIUFHCSA-N Pro-Lys-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VWHJZETTZDAGOM-XUXIUFHCSA-N 0.000 description 1
- KLOQCCRTPHPIFN-DCAQKATOSA-N Pro-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@@H]1CCCN1 KLOQCCRTPHPIFN-DCAQKATOSA-N 0.000 description 1
- KIDXAAQVMNLJFQ-KZVJFYERSA-N Pro-Thr-Ala Chemical compound C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(O)=O KIDXAAQVMNLJFQ-KZVJFYERSA-N 0.000 description 1
- OQSGBXGNAFQGGS-CYDGBPFRSA-N Pro-Val-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OQSGBXGNAFQGGS-CYDGBPFRSA-N 0.000 description 1
- 101100401000 Saccharomyces cerevisiae MEL2 gene Proteins 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- WNDUPCKKKGSKIQ-CIUDSAMLSA-N Ser-Pro-Gln Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O WNDUPCKKKGSKIQ-CIUDSAMLSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- SZRNDHWMVSFPSP-XKBZYTNZSA-N Ser-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N)O SZRNDHWMVSFPSP-XKBZYTNZSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 1
- PQLXHSACXPGWPD-GSSVUCPTSA-N Thr-Asn-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PQLXHSACXPGWPD-GSSVUCPTSA-N 0.000 description 1
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 1
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 1
- XUGYQLFEJYZOKQ-NGTWOADLSA-N Thr-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XUGYQLFEJYZOKQ-NGTWOADLSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- VUXIQSUQQYNLJP-XAVMHZPKSA-N Thr-Ser-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N)O VUXIQSUQQYNLJP-XAVMHZPKSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- GWQUSADRQCTMHN-NWLDYVSISA-N Trp-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O GWQUSADRQCTMHN-NWLDYVSISA-N 0.000 description 1
- DKKHULUSOSWGHS-UWJYBYFXSA-N Tyr-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DKKHULUSOSWGHS-UWJYBYFXSA-N 0.000 description 1
- NXRGXTBPMOGFID-CFMVVWHZSA-N Tyr-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O NXRGXTBPMOGFID-CFMVVWHZSA-N 0.000 description 1
- KIJLSRYAUGGZIN-CFMVVWHZSA-N Tyr-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KIJLSRYAUGGZIN-CFMVVWHZSA-N 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 1
- PTFPUAXGIKTVNN-ONGXEEELSA-N Val-His-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)NCC(=O)O)N PTFPUAXGIKTVNN-ONGXEEELSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- UEPLNXPLHJUYPT-AVGNSLFASA-N Val-Met-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O UEPLNXPLHJUYPT-AVGNSLFASA-N 0.000 description 1
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- WHNSHJJNWNSTSU-BZSNNMDCSA-N Val-Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 WHNSHJJNWNSTSU-BZSNNMDCSA-N 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 108010009297 diglycyl-histidine Proteins 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 108010050343 histidyl-alanyl-glutamine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000001002 morphogenetic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- MXHCPCSDRGLRER-UHFFFAOYSA-N pentaglycine Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(O)=O MXHCPCSDRGLRER-UHFFFAOYSA-N 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 108010000998 wheylin-2 peptide Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
- C12N15/8289—Male sterility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses an application of LEPTO1 protein and a coding gene thereof in regulation and control of male fertility of plants. The invention provides the use of a substance which inhibits the activity and/or level of LEPTO1 protein in the cultivation of male sterile plants; or the substance which inhibits or reduces the expression of the gene coding for the LEPTO1 protein in the cultivation of male sterile plants. The inventors of the invention knock out the gene in wild type rice by CRISPR-Cas9 gene editing technology, which can cause the development of pollen mother cells to be arrested in the early thin line stage and lead to chromosome degradation and final pollen abortion. The site-directed mutagenesis of the LEPTO1 protein coding gene by adopting a tissue-specific gene knockout technology can be used for rice fertility control and hybrid seed production, so that the invention has important significance in rice breeding and can provide important biological resources for increasing the rice yield and improving the rice quality.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to an application of LEPTO1 and a coded protein thereof in rice fertility control.
Background
Rice is one of the most important food crops in the world, and rice is used as food in nearly half of the world population. The rice is the first large grain crop in China, so that the key problem in agricultural production in China is how to improve the yield of the rice. With the influence of factors such as the increase of the population of the world, the reduction of the cultivated land area, the deterioration of the climatic conditions and the like, the requirement of the mankind on the increase of the rice yield is increasingly highlighted. In two 'green revolution', the yield per unit of rice is increased in a breakthrough way. The first green revolution occurs in the middle of the 20 th century, and is mainly characterized in that high stems of rice are changed into short stems, the yield of the rice is greatly improved along with the popularization of short stem varieties, and the problem of food self-sufficiency in many countries is solved. The second green revolution occurs in the second half of the 20 th century, and hybrid rice in China is an outstanding representative of the second green revolution. The hybrid rice fully utilizes the heterosis of the rice, realizes the dramatic improvement of the rice yield, and creates huge economic benefits all over the world.
Hybrid rice is bred by a three-line breeding method. The three lines include male sterile line, maintainer line and restoring line. Male sterile line refers to rice with male degenerated but normal pistils. The fertilization and fructification can be realized only by foreign pollen. The maintainer line is rice with normal development of both stamen and pistil, and features that its progeny is still sterile after pollination to sterile line with its pollen. The restoring line is also rice with stamens and pistils capable of developing normally, and features that the stamens of hybrid seeds produced after pollination of sterile line with its pollen can develop normally and can be selfed to fruit. The key of the three-line breeding method for breeding hybrid rice is to find a suitable male sterile line. However, male sterile plants in nature are rare and difficult to identify. Therefore, the genetic engineering approach to obtain male sterile lines is an important direction for cross breeding.
Meiosis is a special division pattern of a cell that undergoes two cell divisions once DNA replication when a eukaryote forms a gamete. Gametes with halved chromosome number are produced by meiosis, and chromosome is doubled by fertilization to maintain chromosome number stability. An important event after meiosis initiation is fine line phase morphogenesis. To date, two genes MEL1 and MEL2, which are involved in rice growth in the fine line phase, have been co-cloned in rice.
In recent years, the rapid development of gene editing techniques typified by CRISPR-Cas9 has enabled techniques for site-directed editing of genes. Because of its simple and efficient characteristics, it has been widely used in gene editing of animals and plants.
Disclosure of Invention
It is an object of the present invention to provide the use of a substance which inhibits the activity and/or amount of LEPTO1 protein.
The invention provides the use of a substance which inhibits the activity and/or level of LEPTO1 protein in the cultivation of male sterile plants;
the invention also provides the application of the substance for inhibiting or reducing the expression of the LEPTO1 protein coding gene in breeding male sterile plants;
the LEPTO1 protein is (a) or (b) or (c) as follows:
(a) a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table;
(b) a protein derived from rice, having 98% or more identity to (a), and being associated with male fertility of a plant;
(c) and (b) a protein which is obtained by substituting and/or deleting and/or adding one or more amino acid residues to the amino acid sequence shown in the sequence 2 in the sequence table and is related to the male fertility of the plant.
In the application, the substance is a CRISPR-Cas 9system, the system expresses a Cas9 protein gene and a sgRNA gene, and a target sequence of the sgRNA is shown as a sequence 4 in a sequence table. The system can be a vector, and the gene of the Cas9 protein and the gene of the sgRNA can be in the same vector or different vectors.
It is another object of the present invention to provide a method for breeding male sterile plants.
The invention provides a method for cultivating male sterile plants, which comprises the following steps: inhibiting the expression of an LEPTO1 protein coding gene in a target plant to obtain a male sterile plant;
the LEPTO1 protein is (a) or (b) or (c) as follows:
(a) a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table;
(b) a protein derived from rice, having 98% or more identity to (a), and being associated with male fertility of a plant;
(c) and (b) a protein which is obtained by substituting and/or deleting and/or adding one or more amino acid residues to the amino acid sequence shown in the sequence 2 in the sequence table and is related to the male fertility of the plant.
The encoding gene of the LEPTO1 protein is a DNA molecule of 1) or 2) or 3) or 4) or 5) as follows:
1) the coding region is shown as the DNA molecule at the 351-2231 site of the sequence 1 in the sequence table;
2) DNA molecule shown in sequence 1 in the sequence table;
3) DNA molecules which are derived from rice, have more than 98 percent of homology with the DNA sequences limited by the 1) or the 2) and code plant male fertility related proteins;
4) a DNA molecule which is hybridized with the DNA sequence defined in 1) or 2) under strict conditions and encodes a plant male fertility related protein;
5) a DNA molecule which has more than 90 percent of homology with the DNA sequence defined by 1) or 2) and encodes the plant male fertility related protein.
The invention also provides a method for cultivating male sterile plants, which comprises the following steps: reducing or inhibiting the activity and/or content of LEPTO1 protein in a target plant to obtain a male sterile plant;
the LEPTO1 protein is (a) or (b) or (c) as follows:
(a) a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table;
(b) a protein derived from rice, having 98% or more identity to (a), and being associated with male fertility of a plant;
(c) and (b) a protein which is obtained by substituting and/or deleting and/or adding one or more amino acid residues to the amino acid sequence shown in the sequence 2 in the sequence table and is related to the male fertility of the plant.
In the above, reducing or inhibiting the expression or activity of LEPTO1 protein in a plant of interest; or the expression of the LEPTO1 protein coding gene in the target plant is inhibited by adopting CRISPR-Cas9 site-directed mutagenesis LEPTO1 protein coding gene, wherein in the CRISPR-Cas9 site-directed mutagenesis, the target sequence of sgRNA is shown as a sequence 4 in a sequence table.
The CRISPR-Cas9 site-directed mutagenesis LEPTO1 protein encoding gene is realized by introducing a recombinant plasmid into a target plant; the recombinant plasmid has a gene for expressing Cas9 protein and a gene for expressing sgRNA, and the target sequence of the sgRNA is shown as a sequence 4 in a sequence table. In the embodiment of the invention, the recombinant plasmid is pCAMBIA1300-cas9-gRNA, the plasmid is a recombinant plasmid obtained by inserting a DNA molecule shown in a sequence 3 of a sequence table into a multiple cloning site (for example, between BamHI and KpnI enzyme cutting sites) of a pCAMBIA1300-cas9 vector, the plasmid expresses sgRNA, and the target sequence of the sgRNA is shown in a sequence 4 of the sequence table.
The invention also protects a sgRNA, and the target sequence of the sgRNA is shown as a sequence 4 in the sequence table.
The invention also discloses a recombinant plasmid, wherein the recombinant plasmid has a gene for expressing the Cas9 protein and a gene for expressing the sgRNA, and the target sequence of the sgRNA is shown as a sequence 4 in the sequence table. The recombinant plasmid can be specifically a recombinant plasmid pCAMBIA1300-cas 9-gRNA. The recombinant plasmid pCAMBIA1300-cas9-gRNA is: the recombinant plasmid is obtained by inserting a DNA molecule shown in a sequence 3 of a sequence table into a multiple cloning site (for example, between BamHI and KpnI enzyme cutting sites) of a pCAMBIA1300-cas9 vector.
The invention also protects a protein (LEPTO1 protein) which is (a) or (b) or (c) as follows:
(a) a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table;
(b) a protein derived from rice, having 98% or more identity to (a), and being associated with male fertility of a plant;
(c) and (b) a protein which is obtained by substituting and/or deleting and/or adding one or more amino acid residues to the amino acid sequence shown in the sequence 2 in the sequence table and is related to the male fertility of the plant.
Nucleic acid molecules encoding the LEPTO1 protein are also within the scope of the invention, and are in particular DNA molecules of 1) or 2) or 3) or 4) or 5) as follows:
1) the coding region is shown as the DNA molecule at the 351-2231 site of the sequence 1 in the sequence table;
2) DNA molecule shown in sequence 1 in the sequence table;
3) DNA molecules which are derived from rice, have more than 98 percent of homology with the DNA sequences limited by the 1) or the 2) and code plant male fertility related proteins;
4) a DNA molecule which is hybridized with the DNA sequence defined in 1) or 2) under strict conditions and encodes a plant male fertility related protein;
5) a DNA molecule which has more than 90 percent of homology with the DNA sequence defined by 1) or 2) and encodes the plant male fertility related protein.
The invention also protects the application of any one of the methods, the protein, the nucleic acid molecule, the sgRNA or the recombinant plasmid in plant breeding.
Any one of the above male sterility is embodied as complete abortion of all pollen.
Any of the above plants is a monocot or a dicot. The monocotyledon is a gramineous plant. The gramineous plant is a plant of the genus oryza. The Oryza plant is rice. The rice can be specifically No. 8 salt rice.
The invention is provided with60A sterile mutant LEPTO1 is obtained from the material of indica rice Guang-Lu-dwarf No. 4 by a Co-gamma radiation mutagenesis method, and a mutant gene LEPTO1 is separated by a map-based cloning method. By combining cell biology and genetics, the LEPTO1 mutation was found to cause a fine line morphogenetic defect, resulting in a pollenless phenotype. The cloning of the gene provides a way for artificially producing a male sterile line. The invention can be used for rice fertility control and hybrid seed production by combining a CRISPR-Cas9 gene editing method and adopting a tissue-specific gene knockout technology to carry out site-directed mutagenesis on the LEPTO1 protein coding gene, so that the invention has important significance in rice breeding and can provide important biological resources for increasing the rice yield and improving the rice quality.
Drawings
FIG. 1 shows that leptin 1 is a pollen-free phenotype mutant.
Fig. 2 shows the expression pattern of LEPTO1 gene.
FIG. 3 shows that meiosis of lepto1 pollen mother cells stagnated in the fine line phase.
FIG. 4 shows phenotypic identification of leptin 1-cas 9.
Detailed Description
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The quantitative tests in the following examples, all set up three replicates and the results averaged.
The indica rice variety Guang-Lu-dwarf No. 4 is called Guang-Lu-dwarf No. 4 for short. The rice variety saline rice No. 8 is called saline rice No. 8 for short. References to SK-gRNA vectors and pC1300-Cas9 vectors (also known as pCAMBIA1300-Cas 9): wang, C.C., Shen, L.Ful.Y., Yan, C.Wang, K. (2015) A Simple CRISPR/Cas9System for Multiplex genome editing in Rice. journal of Genetics and Genomics 42(2015) 703-706.
Example 1 cloning of the LEPTO1 Gene
1. Phenotypic analysis of leptin 1
The method is carried out on indica rice variety Guang-Lu-dwarf No. 460Performing Co-gamma radiation mutagenesis to obtain a series of mutants.
The results of comparison of the mutant leptin 1 with wild type Guangdong dwarf No. 4 are shown in FIG. 1, (A) wild type (left) and leptin 1 (right) plants; (B) spike comparison of wild type (left) with leptin 1 (right); (C) comparison of floret morphologies of wild type (left) and leptin 1 (right); (D) wild type anther I2KI dyeing; (E) i of leptin 1 anther2KI staining. Scale, 10 μm; of these, leptin 1 showed no significant difference from wild type at vegetative growth stage, but appeared to be weak (FIGS. 1A and 1B). However, compared to wild type, the anthers of leptin 1 were small and appeared white (FIG. 1C), I2KI staining indicated that leptin 1 exhibited a pollen-free phenotype (FIGS. 1D and 1E).
2. Map-based cloning of mutant genes
Crossing the plant capable of producing shape separated progeny (fertile and sterile) with japonica rice variety Wuyujing No. 8, and pairing F2210 sterile individuals of (1) and F3450 sterile individuals in the strain are subjected to initial positioning analysis of mutant genes. The STS molecular marker is used to locate the gene in the 120kb interval on the short arm of chromosome 2. Sequencing revealed that the sterile plants have 7 base deletions in the fifth exon of the gene LOC _ Os02g 08500.
TABLE 1 map-based molecular cloning marker
3. Obtaining of full-Length cDNA of LEPTO1 Gene
The cDNA (sequence 1) with 2486bp of the gene full length is obtained by Rapid Amplification of CDNA End (RACE), and the open reading frame of the gene is the 351-2231 th site of the sequence 1; the gene is named as LEPTO1, the protein coded by the gene is named as LEPTO1, and the amino acid sequence of the protein is sequence 2.
Example 2 expression Pattern of the LEPTO1 Gene
1. Real-time quantitative PCR
The expression level of the LEPTO1 gene in roots, internodes, leaves and ears of Guangdong dwarf No. 4 is detected by a real-time quantitative PCR method, and the expression level of the LEPTO1 gene in the young ears of the leptin 1 mutant (LEPTO1) is detected. The Ubiquitin gene serves as an internal reference.
The results are shown in FIG. 2A, R, root; in, internode; l, leaf; p1, 1cm ear; p2, 2cm ear; p3, 3cm ear; p4, 4cm ear; p10, 10cm ear. Ubiquitin as an internal reference, error bars represent standard errors for three biological replicates; the expression of LEPTO1 in different tissues is shown, and the expression level is highest in 1cm long spikes.
2. In situ hybridization
The pollen of Guangdong dwarf No. 4 is taken and subjected to RNA in situ hybridization to analyze the precise space-time expression pattern of the LEPTO1 gene.
The results are shown in FIGS. 2B-2G (2B, two-stage; 2C, three-stage; 2D and 2E, four-stage early; 2F, bold line; 2G, sense probe control (sense probe RNA sequence CCUCUUGAGUCGAGCAAUCAGCAACACCUUAGUCGGGUGCAUUCAUCUUCUGCAGAUCCAUUUAGCACACUUGUUGGUGAGUCUCCCCAGUUUCCUGAUCUUGGAAGAACCACCAAUACUUGGCAAACUGCGGUUCCAUCCAACAUUCAGGAUCGUGGUCACAAUGAUAACAUGUCGCAAGCCACCCUGCAUAUGAAUGGCCCCAAAAUUGAACCUGUCUCAAGCUUCACAUCAUCCAAUCAGAUUCCGCUGCUGGGAAAUGAGAUGCAGGGCCAAGUAGCAUCACUAGCUAGCAAUGUUCCA), scale, 5 μm, indicating that LEPTO1 is highly expressed in anther three-stage and four-stage early and that the expression of LEPTO1 is mainly concentrated in pollen mother cells.
Example 3 cytological phenotypic analysis of leptin 1
To determine the cause of pollen-free mutant leptin 1, chromosomal behavior was observed in pollen mother cells of the Guangdong dwarf No. 4 (wild type) and leptin 1 mutants by DAPI staining of knocked-out floret slides and anther semi-thin resin sections.
The results are shown in FIG. 3, (A) chromosome morphology in wild type and in lepto1 knocked-out floret pollen mother cells; (B) DAPI staining observation of wild type anther semi-thin resin sections; (C) DAPI staining of the semithin resin sections of leptin 1 anthers; scale, 10 μm; it can be seen that, in the wild type, the first period after the onset of meiosis is the anterior thin line period, at which time chromosomes are scattered and partially agglutinated; in the early fine line phase, the chromosomes stretch out. In the fine line phase, chromosomes process into long lines; in the leptin 1, the observation of florets with different sizes shows that the chromosomes are in a state similar to the wild-type chromosome in the early thin line stage in a longer period of pollen mother cell development, which indicates that the development of the leptin 1 pollen mother cell is stagnated in the early thin line stage; eventually, chromosomes are degraded in the lepto1 pollen mother cells.
Example 4 site-directed mutagenesis of the LEPTO1 Gene
Construction of recombinant plasmid
1. Single-stranded DNA molecules LEPTO1-CAS9-F and LEPTO1-CAS9-R were synthesized separately and then annealed together to give double-stranded DNA molecules having sticky ends at both ends.
LEPTO1-CAS9-F:ggcaCCAGTTCCCGGTCGGCATGC
LEPTO1-CAS9-R:aaacGCATGCCGACCGGGAACTGG
2. And (3) carrying out enzyme digestion on the SK-gRNA vector by using a restriction enzyme AarI, and recovering the linearized vector framework.
3. And (3) connecting the double-stranded DNA molecules obtained in the step (1) with the linearized vector skeleton obtained in the step (2) to obtain recombinant plasmids.
4. Taking the recombinant plasmid obtained in the step 3, carrying out double enzyme digestion by using restriction enzymes BamHI and KpnI, and recovering a small fragment.
5. Taking the pCAMBIA1300-cas9 vector, carrying out double enzyme digestion by using restriction enzymes BamHI and KpnI, and recovering a large fragment.
6. And (3) connecting the small fragment obtained in the step (4) with the large fragment obtained in the step (5) to obtain a recombinant plasmid pCAMBIA1300-cas 9-gRNA. According to the sequencing results, the recombinant plasmid pCAMBIA1300-cas9-gRNA was structurally described as follows: a DNA molecule shown in a sequence 3 of a sequence table is inserted between BamHI enzyme cutting sites and KpnI enzyme cutting sites of a pCAMBIA1300-cas9 vector to express sgRNA.
The target sequence of the sgRNA is sequence 4.
II, obtaining mutant strains
And (2) introducing the recombinant plasmid pCAMBIA1300-cas9-gRNA into agrobacterium EHA105 to obtain recombinant agrobacterium, infecting embryonic callus of the No. 8 oryza sativa, and culturing to obtain a plant, namely a T0 generation plant.
Whole genome sequencing was performed on oryza sativa No. 8 plants as a recipient of genetic transformation and on all the T0 generation plants obtained. 3 plants mutated in the LEPTO1 gene and homozygous for the mutation were obtained from 25 plants of the T0 generation by whole genome sequencing. Compared with the rice No. 8 plant which is taken as a genetic transformation receptor, the genome of each of the 3 plants has only one nucleotide difference (namely, an insertion mutation is generated and is homozygotic, and the insertion is positioned between 86 and 87 positions of an open reading frame) (the 86 position of the open reading frame is also the 436 position of the sequence 1), the nucleotide difference causes frame shift, so that the LEPTO1 protein can not be effectively expressed, and the 3 plants are named as a LEPTO1-cas9 mutant strain.
The partial sequencing results of the oryza sativa No. 8 plant as a recipient of genetic transformation and the leptin 1-cas9 mutant are shown in fig. 4A.
Tissue culture is carried out on the leptin 1-cas9 mutant strain to obtain a plurality of expanded propagation strains with consistent genome.
Comparison of phenotypes
Multiple strains of the leptin 1-cas9 mutant strain are propagated until the strains are mature, and the strains show male sterile phenotype. The saline rice No. 8 plant is cultured until the plant is mature, and the plant shows a male fertile phenotype.
DAPI staining of anther resin sections was performed on pollen of multiple propagated strains of the leptin 1-cas9 mutant and the SALT Rice No. 8 strain.
As a result, as shown in FIG. 4B (scale, 100 μm), it was found that the chromosomal morphology of leptin 1-cas9 was similar to that of leptin 1, all the expanded strains of the leptin 1-cas9 mutant strain were not pollen-stained, all the pollen was abortion pollen, and the male sterility was 100%. The pollen of the No. 8 plant of the saline rice is normal.
The above results indicate that the mutation of the LEPTO1 gene is indeed responsible for the sterile phenotype of the mutant.
The result shows that the expression of the LEPTO1 gene (the specific implementation mode is CRISPR-Cas9 gene knockout technology) is the cause of male sterility phenotype, and the sterility degree of the pollen can reach 100 percent (namely the pollen is completely aborted).
Sequence listing
<110> institute of genetics and developmental biology of Chinese academy of sciences
<120> LEPTO1 and application of encoding protein thereof in rice fertility control
<160>4
<170>PatentIn version 3.5
<210>1
<211>2486
<212>DNA
<213> Artificial sequence
<400>1
ggaaaataaa ggcgaggagg gaaataaaaa aaaaaggttt ccacctttgc actgcatatg 60
aaattttttt tttctctttc actccaatcc attccattta cccaatccgc gatccatcca 120
tcatccccta cctctcgctc tctctctcct ctcctctcct cttattatca tcgcatccat 180
cccgcacttc tctctctttg gtggtggtgc tcgctctcgc tcaccctgct ttgacctttg 240
gatttttatt tttaaggatc caagaaagtg ctgtttcttg ggttgcttgg aggtggagga 300
gtttgggaga ttgtttgtgt ttgattgatt ggttgattga ttggaggaag atgacggtgg 360
aggagaggca ggggagggtg ggaggccatg gtgtgagcgg cggcggcggc gggagagacc 420
agttcccggt cggcatgcgg gtgctcgccg tcgacgacga ccccacctgc ctcaagatcc 480
tcgagaacct cctgcttcga tgccagtatc acgtgacaac aactggtcag gcggccacgg 540
ccctgaagct gctcagggag aacaaggacc agtttgacct ggtgatcagc gacgtccaca 600
tgccggacat ggatggcttc aaactccttg agcttgtcgg cctcgagatg gacctcccag 660
tcattatgtt gtctgcgaac ggggaaacac aaactgtcat gaagggtata acccatggtg 720
catgtgacta tcttctgaag ccagtgcgtc ttgagcagct aaggacgata tggcaacatg 780
tgattaggcg taagaattgt gatgctaaga accgtggtaa cgatgatgac gctggtcaga 840
aggcacaggg aatgaacaat gaaggtgaga gtattggtgc taaccgcaac aagaggcagt 900
cacggaaaag tagagatgag aatggagatg atggtgatga ttctgatgag aacagtaatg 960
agaatggaga ctcatcaaca cagaagaagc caagggtcgt gtggtctgtt gagctgcacc 1020
gaaagtttgt ggctgctgtt aaccagcttg gcatcgagaa ggctgttcca aagaaaatat 1080
tggatctcat gaatgtagag aacatcacca gggagaatgt tgctagtcat ttgcagaagt 1140
atcggctgta ccttaaacgg ttgagcactg atgcaagcag gcaggctaac cttgcagctg 1200
catttggagg aaggaaccct gcttacataa acatgaattc atttggaaac tacaacgcat 1260
atggtagata ccgtacagtc ccaactgctg gccataccca ggcaaacaac attcttacta 1320
ggatgaactc cccttctgcg tttggtgttc atggtttgct gcattcacag ccaattcagt 1380
taggacatgc ccaaaataat ctgagcactt cactgaatga tttaggaggg cttaataatg 1440
gtaacatgat cagaggtgca cagatgtcaa caattctaac tggtccttct ggtaactcct 1500
ttccaaacat atcgaatggt gcaccgctgg caactgcaaa cagatcactg caacctcttg 1560
agtcgagcaa tcagcaacac cttagtcggg tgcattcatc ttctgcagat ccatttagca 1620
cacttgttgg tgagtctccc cagtttcctg atcttggaag aaccaccaat acttggcaaa 1680
ctgcggttcc atccaacatt caggatcgtg gtcacaatga taacatgtcg caagccaccc 1740
tgcatatgaa tggccccaaa attgaacctg tctcaagctt cacatcatcc aatcagattc 1800
cgctgctggg aaatgagatg cagggccaag tagcatcact agctagcaat gttccaatag 1860
cattcaatca ggacacatca ccattcaact atggaagcag cacaaactca agagacatgc 1920
taaataacag ccatgtattt agtaactcca gcatcaacac atcgttgccc aaccttagct 1980
tagacaatcc ggctgtacca aggcagacac tggatcgtgg gaatacgggc attgtttctc 2040
ccatgcaaga tggaaggatt catcaccaag ctgttagcaa tcagctaaac tataatgacg 2100
atcttatgcg gacaactggg ctgcaaaggg gtctcagtgg tggtctagat gacattgttg 2160
ttgacatgtt taggccggac cgcgaagacg acggcgttcc ttacatcgat ggggactggg 2220
agctggtcta gccagcctcc atttcaatca ttagtccgcg tacgaggttt ttctgcattc 2280
gcggtgtcgg ctgctgattg gtccatgctc acttgtcagc acaaagtggt gttcatagtg 2340
gctagccttc atcacaagtg catttcacat ttggcttctt ttttcagctt agtgattatt 2400
agttggccag tcagtctgtg aaatttatgt ggagaaacgg ctatgtggtg tgtttttatc 2460
atgacttata ctataataac tatgtt 2486
<210>2
<211>626
<212>PRT
<213> Artificial sequence
<400>2
Met Thr Val Glu Glu Arg Gln Gly Arg Val Gly Gly His Gly Val Ser
1 5 10 15
Gly Gly Gly Gly Gly Arg Asp Gln Phe Pro Val Gly Met Arg Val Leu
20 25 30
Ala Val Asp Asp Asp Pro Thr Cys Leu Lys Ile Leu Glu Asn Leu Leu
35 40 45
Leu Arg Cys Gln Tyr His Val Thr Thr Thr Gly Gln Ala Ala Thr Ala
50 55 60
Leu Lys Leu Leu Arg Glu Asn Lys Asp Gln Phe Asp Leu Val Ile Ser
65 70 75 80
Asp Val His Met Pro Asp Met Asp Gly Phe Lys Leu Leu Glu Leu Val
85 90 95
Gly Leu Glu Met Asp Leu Pro Val Ile Met Leu Ser Ala Asn Gly Glu
100 105 110
Thr Gln Thr Val Met Lys Gly Ile Thr His Gly Ala Cys Asp Tyr Leu
115 120 125
Leu Lys Pro Val Arg Leu Glu Gln Leu Arg Thr Ile Trp Gln His Val
130 135 140
Ile Arg Arg Lys Asn Cys Asp Ala Lys Asn Arg Gly Asn Asp Asp Asp
145 150 155 160
Ala Gly Gln Lys Ala Gln Gly Met Asn Asn Glu Gly Glu Ser Ile Gly
165 170 175
Ala Asn Arg Asn Lys Arg Gln Ser Arg Lys Ser Arg Asp Glu Asn Gly
180 185 190
Asp Asp Gly Asp Asp Ser Asp Glu Asn Ser Asn Glu Asn Gly Asp Ser
195 200 205
Ser Thr Gln Lys Lys Pro Arg Val Val Trp Ser Val Glu Leu His Arg
210 215 220
Lys Phe Val Ala Ala Val Asn Gln Leu Gly Ile Glu Lys Ala Val Pro
225 230 235 240
Lys Lys Ile Leu Asp Leu Met Asn Val Glu Asn Ile Thr Arg Glu Asn
245 250 255
Val Ala Ser His Leu Gln Lys Tyr Arg Leu Tyr Leu Lys Arg Leu Ser
260 265 270
Thr Asp Ala Ser Arg Gln Ala Asn Leu Ala Ala Ala Phe Gly Gly Arg
275 280 285
Asn Pro Ala Tyr Ile Asn Met Asn Ser Phe Gly Asn Tyr Asn Ala Tyr
290 295 300
Gly Arg Tyr Arg Thr Val Pro Thr Ala Gly His Thr Gln Ala Asn Asn
305 310 315 320
Ile Leu Thr Arg Met Asn Ser Pro Ser Ala Phe Gly Val His Gly Leu
325 330 335
Leu His Ser Gln Pro Ile Gln Leu Gly His Ala Gln Asn Asn Leu Ser
340 345 350
Thr Ser Leu Asn Asp Leu Gly Gly Leu Asn Asn Gly Asn Met Ile Arg
355 360 365
Gly Ala Gln Met Ser Thr Ile Leu Thr Gly Pro Ser Gly Asn Ser Phe
370 375 380
Pro Asn Ile Ser Asn Gly Ala Pro Leu Ala Thr Ala Asn Arg Ser Leu
385 390 395 400
Gln Pro Leu Glu Ser Ser Asn Gln Gln His Leu Ser Arg Val His Ser
405 410 415
Ser Ser Ala Asp Pro Phe Ser Thr Leu Val Gly Glu Ser Pro Gln Phe
420 425 430
Pro Asp Leu Gly Arg Thr Thr Asn Thr Trp Gln Thr Ala Val Pro Ser
435 440 445
Asn Ile Gln Asp Arg Gly His Asn Asp Asn Met Ser Gln Ala Thr Leu
450 455 460
His Met Asn Gly Pro Lys Ile Glu Pro Val Ser Ser Phe Thr Ser Ser
465 470 475 480
Asn Gln Ile Pro Leu Leu Gly Asn Glu Met Gln Gly Gln Val Ala Ser
485 490 495
Leu Ala Ser Asn Val Pro Ile Ala Phe Asn Gln Asp Thr Ser Pro Phe
500 505 510
Asn Tyr Gly Ser Ser Thr Asn Ser Arg Asp Met Leu Asn Asn Ser His
515 520 525
Val Phe Ser Asn Ser Ser Ile Asn Thr Ser Leu Pro Asn Leu Ser Leu
530 535 540
Asp Asn Pro Ala Val Pro Arg Gln Thr Leu Asp Arg Gly Asn Thr Gly
545 550 555 560
Ile Val Ser Pro Met Gln Asp Gly Arg Ile His His Gln Ala Val Ser
565 570 575
Asn Gln Leu Asn Tyr Asn Asp Asp Leu Met Arg Thr Thr Gly Leu Gln
580 585 590
Arg Gly Leu Ser Gly Gly Leu Asp Asp Ile Val Val Asp Met Phe Arg
595 600 605
Pro Asp Arg Glu Asp Asp Gly Val Pro Tyr Ile Asp Gly Asp Trp Glu
610 615 620
Leu Val
625
<210>3
<211>530
<212>DNA
<213> Artificial sequence
<400>3
ggatccgtcg acgattaagg aatctttaaa catacgaaca gatcacttaa agttcttctg 60
aagcaactta aagttatcag gcatgcatgg atcttggagg aatcagatgt gcagtcaggg 120
accatagcac aagacaggcg tcttctactg gtgctaccag caaatgctgg aagccgggaa 180
cactgggtac gtcggaaacc acgtgatgtg aagaagtaag ataaactgta ggagaaaagc 240
atttcgtagt gggccatgaa gcctttcagg acatgtattg cagtatgggc cggcccatta 300
cgcaattgga cgacaacaaa gactagtatt agtaccacct cggctatcca catagatcaa 360
agctgattta aaagagttgt gcagatgatc cgtggcacca gttcccggtc ggcatgcgtt 420
ttagagctag aaatagcaag ttaaaataag gctagtccgt tatcaacttg aaaaagtggc 480
accgagtcgg tgcttttttt ccacataatc tctagaagat cttcggtacc 530
<210>4
<211>20
<212>DNA
<213> Artificial sequence
<400>4
ccagttcccg gtcggcatgc 20
Claims (5)
- The application of the LEPTO1 protein or the encoding gene of the LEPTO1 protein in breeding male sterile plants;the LEPTO1 protein is a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table.
- 2. The use of a substance which inhibits the activity and/or content of LEPTO1 protein in the cultivation of male sterile plants;or the application of the substance for inhibiting or reducing the expression of the LEPTO1 protein coding gene in the cultivation of male sterile plants;the LEPTO1 protein is a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table;the substance is a CRISPR-Cas 9system, the CRISPR-Cas 9system expresses a Cas9 protein gene and a sgRNA gene, and a target sequence of the sgRNA is shown as a sequence 4 in a sequence table.
- 3. A method of breeding male sterile plants comprising the steps of: reducing or inhibiting the activity and/or content of LEPTO1 protein in a target plant to obtain a male sterile plant;the LEPTO1 protein is a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table.
- 4. A method of breeding male sterile plants comprising the steps of: inhibiting the expression of the LEPTO1 protein coding gene in the target plant to obtain a male sterile plant:the LEPTO1 protein is a protein consisting of an amino acid sequence shown in a sequence 2 in a sequence table.
- 5. The method of claim 4, wherein: the LEPTO1 protein coding gene is a DNA molecule of the following 1) or 2):1) the coding region is shown as the DNA molecule at the 351-2231 site of the sequence 1 in the sequence table;2) DNA molecule shown in sequence 1 in the sequence table.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811452764.9A CN109354615B (en) | 2018-11-30 | 2018-11-30 | LEPTO1 and application of encoding protein thereof in rice fertility control |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811452764.9A CN109354615B (en) | 2018-11-30 | 2018-11-30 | LEPTO1 and application of encoding protein thereof in rice fertility control |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109354615A CN109354615A (en) | 2019-02-19 |
CN109354615B true CN109354615B (en) | 2020-11-03 |
Family
ID=65330260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811452764.9A Active CN109354615B (en) | 2018-11-30 | 2018-11-30 | LEPTO1 and application of encoding protein thereof in rice fertility control |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109354615B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102766631B (en) * | 2012-07-20 | 2013-11-06 | 中国农业大学 | Application of OsSPX1 protein and encoding gene of OsSPX1 protein in regulation of plant pollen fertility |
-
2018
- 2018-11-30 CN CN201811452764.9A patent/CN109354615B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN109354615A (en) | 2019-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3978613A1 (en) | Parthenogenetic haploid induction gene dmp and application thereof | |
CN109207513B (en) | Application of DCM1 protein and coding gene thereof in regulation and control of male fertility of plant | |
CN111153974A (en) | Corn disease-resistant gene and molecular marker and application thereof | |
CN112899247B (en) | Male sterile gene ZmTKPR1 and application thereof in creating male sterile line of corn | |
KR20210023827A (en) | Restorative Locus for the Cytoplasmic Male Infertility System of Bacatum in Pepper | |
AU2017336342B2 (en) | Parthenocarpic watermelon plants | |
CN112680459B (en) | Male sterile gene ZmTGA10 and application thereof in creating male sterile line of corn | |
EP4240143A1 (en) | Parthenocarpic watermelon plants | |
CN109837295A (en) | A kind of the rice haploid inducing line and its method for creating of gene editing initiative and application | |
CN103130884B (en) | Protein relevant to plant spike shape and encoding gene and appliance thereof | |
CN110167339B (en) | Productive flowering watermelon | |
US11761017B2 (en) | Rice thermo-sensitive male sterile gene mutant tms18 and uses thereof | |
CN109354615B (en) | LEPTO1 and application of encoding protein thereof in rice fertility control | |
US20230371453A1 (en) | Parthenocarpic watermelon plants | |
CN113429468B (en) | Barley male sterility gene msg3002 and application thereof | |
CN109161551A (en) | Wild cabbage BoMS1 gene and its application in initiative sterile material | |
CN110642930B (en) | Gene for regulating and controlling tillering number of corn, and encoded protein and application thereof | |
CN114525300A (en) | Application of polynucleotide and protein and haploid inducing line thereof | |
CN114107324A (en) | Rice low temperature resistance related gene and application thereof | |
EP4038193A1 (en) | Begomovirus resistance related genes | |
CN104031132A (en) | Plant peduncle development related protein, and coding gene and application thereof | |
CN110903369B (en) | Application of AOC3 protein in regulating and controlling thickness of plant bracts | |
US20230348931A1 (en) | Cytoplasmic Male-Sterile Rudbeckia Plants and a Method of Production | |
OA21227A (en) | Parthenocarpic watermelon plants. | |
OA21301A (en) | Parthenocarpic watermelon plants. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |